These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23807676)

  • 21. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.
    Neuhouser ML; Manson JE; Millen A; Pettinger M; Margolis K; Jacobs ET; Shikany JM; Vitolins M; Adams-Campbell L; Liu S; LeBlanc E; Johnson KC; Wactawski-Wende J
    Am J Epidemiol; 2012 Apr; 175(7):673-84. PubMed ID: 22362582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
    Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
    J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.
    Chen P; Li M; Gu X; Liu Y; Li X; Li C; Wang Y; Xie D; Wang F; Yu C; Li J; Chen X; Chu R; Zhu J; Ou Z; Wang H
    PLoS One; 2013; 8(1):e49312. PubMed ID: 23382798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
    Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
    Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies.
    Ma Y; Zhang P; Wang F; Yang J; Liu Z; Qin H
    J Clin Oncol; 2011 Oct; 29(28):3775-82. PubMed ID: 21876081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Freedman DM; Chang SC; Falk RT; Purdue MP; Huang WY; McCarty CA; Hollis BW; Graubard BI; Berg CD; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):889-94. PubMed ID: 18381472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum 25-Hydroxyvitamin D Levels and Depression in Older Adults: A Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Li H; Sun D; Wang A; Pan H; Feng W; Ng CH; Ungvari GS; Tao L; Li X; Wang W; Xiang YT; Guo X
    Am J Geriatr Psychiatry; 2019 Nov; 27(11):1192-1202. PubMed ID: 31262683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D exposure and Risk of Breast Cancer: a meta-analysis.
    Estébanez N; Gómez-Acebo I; Palazuelos C; Llorca J; Dierssen-Sotos T
    Sci Rep; 2018 Jun; 8(1):9039. PubMed ID: 29899554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum.
    Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF
    Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
    Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
    Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.
    Wang J; Eliassen AH; Spiegelman D; Willett WC; Hankinson SE
    Cancer Causes Control; 2014 Jul; 25(7):819-27. PubMed ID: 24748579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
    Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
    Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
    Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
    Bilinski K; Boyages J
    Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
    Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
    Yao S; Sucheston LE; Millen AE; Johnson CS; Trump DL; Nesline MK; Davis W; Hong CC; McCann SE; Hwang H; Kulkarni S; Edge SB; O'Connor TL; Ambrosone CB
    PLoS One; 2011 Feb; 6(2):e17251. PubMed ID: 21386992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
    Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
    Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.